Hjem › Tykktarmskreft › Missouri › Kansas City
Kliniske studier for Tykktarmskreft i Kansas City, MO
8 studier for Tykktarmskreft søker deltakere på steder i og rundt Kansas City (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
RekruttererFrivillige helsepersonell ønskes velkommen
- University Health Truman Medical Center, Kansas City
- University of Kansas Cancer Center - Briarcliff, Kansas City
- University of Kansas Cancer Center - North, Kansas City
- og 1 flere
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
RekruttererFase 3
- Saint Luke's Cancer Institute ( Site 0082), Kansas City
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
RekruttererFase 3
- Saint Luke'S Hospital of Kansas City, Kansas City
- Midamerica Cancer Care, Kansas City
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Rekrutterer
- Kansas City Veterans Affairs Medical Center, Kansas City
- University of Kansas Hospital-Westwood Cancer Center, Westwood · 5 mi unna
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
RekruttererFase 2/3
- Saint Luke's Hospital of Kansas City, Kansas City
Integrated Cancer Repository for Cancer Research
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Saint Luke's Cancer Institute, East, Kansas City
- Saint Luke's Cancer Institute, Kansas City
- Saint Luke's Cancer Institute, Kansas City North, Kansas City
- og 1 flere
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
RekruttererFase 3
- GSK Investigational Site, Westwood · 5 mi unna
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, Kansas City
Tykktarmskreft-studier i andre byer
- Boston, MA22 studier
- New York City, NY22 studier
- Houston, TX20 studier
- Los Angeles, CA16 studier
- Nashville, TN16 studier
- St. Louis, MO15 studier
- Arlington, VA15 studier
- Chicago, IL14 studier
- San Antonio, TX14 studier
- Baldwin Park, CA14 studier
- Baltimore, MD13 studier
- Tampa, FL13 studier
Andre studier i Kansas City
- Brystkreft34 studier
- Ikke-småcellet lungekreft31 studier
- Hjertesvikt25 studier
- Kreft (alle typer)21 studier
- Lungekreft19 studier
- Kolorektal kreft16 studier
- Metastatisk kreft15 studier
- Akut myelogen leukemi15 studier
- Prostatakreft14 studier
- Eggstokkreft11 studier
- Fedme11 studier
- Type 2-diabetes11 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.